Vidipha Central Pharmaceutical JSC (HOSE:VDP)
Vietnam · Delayed Price · Currency is VND 53,000
0.00 (0.00%)
At close: Apr 28, 2026
HOSE:VDP Income Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2008 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '08 Dec 31, 2008 |
| 971,254 | 985,637 | 934,487 | 1,019,317 | 1,007,796 | 206,952 | |
Revenue Growth (YoY) | 4.29% | 5.47% | -8.32% | 1.14% | 386.97% | 8.10% |
Cost of Revenue | 718,509 | 728,568 | 704,748 | 748,737 | 755,408 | 163,049 |
Gross Profit | 252,746 | 257,069 | 229,739 | 270,580 | 252,388 | 43,904 |
Selling, General & Admin | 176,871 | 174,310 | 147,873 | 171,420 | 161,730 | 18,090 |
Operating Expenses | 176,871 | 174,310 | 147,873 | 171,420 | 161,730 | 18,090 |
Operating Income | 75,875 | 82,759 | 81,866 | 99,160 | 90,659 | 25,813 |
Interest Expense | -10,214 | -10,447 | -14,849 | -27,559 | -20,546 | - |
Interest & Investment Income | 14,321 | 14,100 | 14,868 | 17,176 | 7,895 | 4,815 |
Currency Exchange Gain (Loss) | -1,661 | -2,711 | 2,356 | 1,905 | -2,241 | 38.56 |
Other Non Operating Income (Expenses) | 2,363 | -156.46 | 6,112 | 9,313 | 13,763 | 218.06 |
EBT Excluding Unusual Items | 80,684 | 83,545 | 90,353 | 99,996 | 89,530 | 30,885 |
Gain (Loss) on Sale of Investments | - | - | - | 256.95 | 3,783 | -367.05 |
Gain (Loss) on Sale of Assets | - | - | - | 315.45 | - | - |
Pretax Income | 80,684 | 83,545 | 90,353 | 100,569 | 93,314 | 30,518 |
Income Tax Expense | 19,094 | 19,738 | 18,530 | 20,350 | 19,765 | 3,011 |
Net Income | 61,590 | 63,807 | 71,823 | 80,219 | 73,548 | 27,507 |
Net Income to Common | 61,590 | 63,807 | 71,823 | 80,219 | 73,548 | 27,507 |
Net Income Growth | -11.21% | -11.16% | -10.47% | 9.07% | 167.38% | 7.75% |
Shares Outstanding (Basic) | 22 | 22 | 22 | 20 | 20 | 7 |
Shares Outstanding (Diluted) | 22 | 22 | 22 | 20 | 20 | 7 |
Shares Change (YoY) | - | - | 9.33% | - | 180.50% | 9.02% |
EPS (Basic) | 2788.97 | 2889.38 | 3252.36 | 3971.57 | 3641.32 | 3820.00 |
EPS (Diluted) | 2788.97 | 2889.38 | 3252.36 | 3971.57 | 3641.32 | 3820.00 |
EPS Growth | - | -11.16% | -18.11% | 9.07% | -4.68% | -1.16% |
Free Cash Flow | 260,825 | 217,267 | 21,112 | 48,907 | -53,901 | 24,811 |
Free Cash Flow Per Share | 11810.93 | 9838.49 | 956.00 | 2421.35 | -2668.58 | 3445.65 |
Dividend Per Share | - | - | 2500.000 | - | - | - |
Gross Margin | 26.02% | 26.08% | 24.58% | 26.55% | 25.04% | 21.21% |
Operating Margin | 7.81% | 8.40% | 8.76% | 9.73% | 9.00% | 12.47% |
Profit Margin | 6.34% | 6.47% | 7.69% | 7.87% | 7.30% | 13.29% |
Free Cash Flow Margin | 26.85% | 22.04% | 2.26% | 4.80% | -5.35% | 11.99% |
EBITDA | 105,047 | 112,260 | 112,025 | 126,500 | 111,456 | 31,480 |
EBITDA Margin | 10.82% | 11.39% | 11.99% | 12.41% | 11.06% | 15.21% |
D&A For EBITDA | 29,173 | 29,501 | 30,159 | 27,340 | 20,798 | 5,666 |
EBIT | 75,875 | 82,759 | 81,866 | 99,160 | 90,659 | 25,813 |
EBIT Margin | 7.81% | 8.40% | 8.76% | 9.73% | 9.00% | 12.47% |
Effective Tax Rate | 23.66% | 23.63% | 20.51% | 20.23% | 21.18% | 9.87% |
Revenue as Reported | 971,254 | 985,637 | 934,487 | 1,019,317 | 1,007,796 | 206,952 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.